The Baculoviridae are a family of insect pathogens with large supercoiled dsDNA genomes of 88 to 163 kb. They are characterized by a complex infection cycle in which nucleocapsids are associated with two structurally distinct virion phenotypes. The polyhedra-derived virus (PDV) phenotype consists of nucleocapsids that become enveloped in the cell nucleus by a membrane assembled de novo and then are occluded in polyhedron-shaped occlusion bodies or polyhedra. Polyhedra released upon the death of the insect may remain viable for extended periods, thereby disseminating the virus to other insects. In contrast, nucleocapsids associated with the budded virus (BV) phenotype are not occluded. After assembling in the nucleus, they move to the cell surface where they derive their membrane by budding through a virusmodified plasma membrane and disseminate the infection from cell to cell within the host insect.
Although the PDV and BV phenotypes serve different functions in the baculovirus infection cycle, the nucleocapsids appear to be structurally similar (see review by Rohrmann, 1992) . In addition to containing the genome and a putative DNA-binding protein of 6.5K to 7.5K (Wilson et al., 1987; Russell & Rohrmann, 1990b; Maeda et al., 1991) , PDV and BV nucleocapsids both appear to have at least two capsid-associated proteins. The p39 protein is a major capsid component and has been described from three NPVs (Pearson et al., 1988; Thiem & Miller, 1989; Bjornson & Rohrmann, 1992b) . In addition, another protein, p87, appears to be present in both Autographa californica multiple nucleocapsid nuclear polyhedrosis virus (AcMNPV) and Orgyia pseudotsugata MNPV capsids (Miiller et aI., 1990; Lu & Carstens, 1991) . In contrast, recent investigations by Kuzio et al. (1989) suggest that a protein called p74 may be a specific component of PDV nucleocapsids that is required for infectivity in insects but not cultured cells.
The protein, p24, is encoded by the first open reading frame (ORF 1) in a series of five late-expressed ORFs in the polyhedron envelope protein gene region in both AcMNPV (Oellig et aI., 1987; Whitford et al., 1989) and OpMNPV (Gombart et al., 1989a) (Fig. l a) . In the E strain of AcMNPV, the p24 gene is interrupted by a transposable element (Gombart et al., 1989a; Schetter et al., 1990) which has no reported effect on the ability of the virus to replicate under laboratory culture conditions. In addition, a homologue of the p24 gene was recently characterized in the Lymantria dispar MNPV (LdMNPV) genome. This homologue was found to be lacking the amino-terminal half of the ORF and encoded a predicted protein of llK (Bjornson & Rohrmann, 1992a) . In contrast to AcMNPV and OpMNPV in which p24 is a late-expressed gene, the p24 gene of LdMNPV lacks a late promoter element. However, it is preceded by an RNA polymerase II promoter consensus sequence shown to be active in an in vitro transcription system, suggesting that p24 is transcribed as an early gene in LdMNPV (Bjornson & Rohrmann, 1992a) .
To determine the possible role of p24 and to trace its expression in OpMNPV-infected cells, we produced a monospecific antiserum against a fusion protein that contained the complete p24 ORF. To generate this gene fusion, a plasmid [pBlueScribe (pBS-); Stratagene] containing the ORF 1 gene region was used. This plasmid was constructed for another study (Gross & Rohrmann, 1993) and had been modified by changing the ORF 1 late promoter element from TGTAAG to a BclI site (TGATCA) (Fig. l b) . A 683 bp BclI-PstI fragment containing the complete p24 gene was isolated and subcloned into the trpE expression vector pATH 11 (Koerner et al., 1991 ) cut with B a m H I and PstI (Fig. 1 b) . The sequence of the fusion junction is shown in Fig. 1 (c) . This construct resulted in a fusion protein of about 58K (37K from trpE and 21.2K from ORF 1) which was expressed, isolated, and used for antibody production as previously described (Gross & Rohrmann, 1990; Gombart et al., 1989b) .
To investigate the time course of expression of p24, extracts from OpMNPV-infected L. dispar and AcMNPV-infected S. frugiperda cells were examined at different times after infection by Western blot analysis using the TrpE-p24 antiserum.
OpMNPV-infected cell extracts were produced using a cloned isolate of OpMNPV (Quant-Russell et al., 1987) to infect L. dispar (Ld-652Y) cells (m.o.i. of 10) that were propagated in T flasks using TNM-FH medium (Summers & Smith, 1987) supplemented with 10% foetal bovine serum (FBS). The E-2 strain of AcMNPV was propagated in S. frugiperda cells (Sf9) in TNM-FH-10 % FBS. AcMNPV was used at an m.o.i, of 10. T N M -F H medium was supplemented with penicillin G (50 units/ ml), streptomycin (50 mg/ml; Whittaker Bioproducts), and fungizone (amphotericin B, 375 ng/ml; Flow Laboratories). Cells were lysed in 2 x SDS-PAGE sample buffer (125mM-Tris-HCl pH 6"8, 4% SDS, 10% 2-mercaptoethanol, 20% glycerol and 0-002% bromophenol blue) and an amount of protein equivalent to approximately 4.8x 104 cells per lane was electrophoresed on a 10 % SDS-polyacrylamide gel (Laemmli, 1970) . Budded virus was isolated from 150 ml shaker cultures of OpMNPV-infected L. dispar cells and AcMNPV-infected S. frugiperda cells at 72 h p.i. After low-speed centrifugation (2000 g for 10 min), the virus was pelleted by centrifugation at 80000 g for 30 min and further purified by centrifugation through a 38 to 52 % sucrose gradient at 80000 g for 2 h at 4 °C. OpMNPV occlusion bodies were isolated as previously described (Rohrmann et at., 1978) . AcMNPV occlusion bodies were the gift of John K uzio. Western blots were prepared as previously described (Quant-Russell et al., 1987) . The TrpE-p24 antiserum was used at a 1 : 1000 dilution. cells were harvested at 84 h p.i., fixed in 2.5 % glutaraldehyde, dehydrated with ethanol, embedded in LR White resin and immunogoldlabelled with 10 nm gold particles as previously described (Russell & Rohrmann, 1990a) . VIR 74
For both viruses, a protein of 24K was stained beginning at 24 h post-infection (p.i.) and was present until 120 h p.i., the last time point assayed (Fig. 2a, b) . These data are consistent with p24 being expressed as a late gene. A number of bands were also observed that were present in the uninfected lanes and throughout the time course indicating that there is some cross-reaction of the antiserum with host cell proteins. A minor band of about 40K that appeared to be infection-specific was also observed in the OpMNPV time course. Controls included the reaction of the TrpE-p24 antiserum with extracts of uninfected insect cells (Fig. 2a, b) and antiTrpE antiserum and preimmune serum reacted with Western blots of infected cells. A protein of 24K was not detected in these controls (data not shown).
To determine whether p24 is associated with a structural component of virions, preparations of BVs and occlusion bodies (OBs) from OpMNPV and AcMNPV were subjected to Western blot analysis. These data indicate that p24 is present in BV (Fig. 2 c, lanes 1  and 3) and OB (lanes 2 and 4) preparations from both viruses.
Although the ORF 1 gene product showed an apparent M r of 24K on Western blots, the Mr predicted from the sequence is 21.2K (Gombart et al., 1989 b) . To determine whether p24 was N-glycosylated, a BV preparation was digested with N-glycanase (Genzyme Corporation) according to the manufacturer's instructions. After digestion, treated and untreated BV preparations were electrophoresed on SDS-PAGE gels and Western blot analysis was performed using the p24 antiserum. These preparations were also reacted with antiserum to an Nglycosylated protein (gp64) that is present in BV preparations to confirm that the N-glycanase was active. Although the gp64 protein was reduced in size from 64K to about 55K by digestion with N-glycanase, p24 was unaffected, indicating that it is not N-glycosylated (data not shown). Similarly, no evidence of N-glycosylation was found when virus was grown in the presence of tunicamycin (data not shown).
To localize the p24 protein more precisely in virions and to examine its location in infected cells, OpMNPVinfected L. dispar cells were examined by immunoelectron microscopy. The p24 antiserum stained chromatin-like material around the margins of the nuclei of cells at 84 h p.i. (Fig. 3a) . In addition, it showed specific staining of both non-occluded and occluded nucleocapsids present in the nucleus (Fig. 3a to d) and also stained nucleocapsids present in the cytoplasm (Fig. 3 d ) . The staining of nucleocapsids appears to be randomly distributed, suggesting that p24 is a component of the capsid as opposed to a specialized end structure. Neither uninfected nor infected cells showed significant staining with the TrpE-p24 or anti-TrpE antisera, respectively (data not shown).
Both Western blot analysis of baculovirus phenotypes from both AcMNPV and OpMNPV and the immunoelectron microscopic examination of OpMNPVinfected cells indicate that p24 is specifically associated with nucleocapsids of both viruses. These data, in combination with previous analyses of baculovirus structure, suggest that baculovirus capsids are composed of at least three components. These include p24, p39 (Pearson et al., 1988; Thiem & Miller, 1989) and p87 (Mfiller et al., 1990; Lu & Carstens, 1991) . Although the data presented in this report indicate that p24 is localized to the virion capsid, p24 was previously shown to be interrupted by a transposable element in the E strain of AcMNPV (Gombart et al., 1989a; Schetter et al., 1990) . This mutation has no reported effects on the ability of the virus to replicate under laboratory culture conditions. To determine whether a portion of the p24 gene is expressed in the E strain of AcMNPV, extracts of Sf9 cells infected with the AcMNPV E strain (a gift from Dr W. Doerfler) were analysed on Western blots using the TrpE-p24 antiserum which normally reacts with p24 in AcMNPV (see Fig. 2b ). No evidence for p24 expression in this strain of AcMNPV was observed (data not shown). In addition it was recently reported that the p24 homologue in the LdMNPV CI 5-6 strain of LdMNPV lacks the amino-terminal half of the p24 (Bjornson & Rohrmann, 1992a) . These data suggest that the complete p24 ORF is not essential for viability of these two virus strains under laboratory culture conditions. In addition, understanding the possible role of the p24 protein is complicated by the observation that the LdMNPV p24 gene is expressed from an RNA polymerase II (early) promoter element (Bjornson & Rohrmann, 1992a) rather than being expressed as a late gene as observed in OpMNPV (Gombart et al., 1989a) . The implications of the variability of the structure and expression of this gene remains to be elucidated.
